Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

CeriBell, Inc.

CBLLNASDAQ
Healthcare
Medical - Devices
$19.73
$-0.57(-2.79%)
U.S. Market is Open • 12:30

CeriBell, Inc. Fundamental Analysis

CeriBell, Inc. (CBLL) shows moderate financial fundamentals with a PE ratio of -14.23, profit margin of -63.35%, and ROE of -29.63%. The company generates $0.1B in annual revenue with strong year-over-year growth of 44.71%.

Key Strengths

Cash Position22.65%
Current Ratio12.50

Areas of Concern

ROE-29.63%
Operating Margin-68.46%
PEG Ratio3.44
We analyze CBLL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -30.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-30.1/100

We analyze CBLL's fundamental strength across five key dimensions:

Efficiency Score

Weak

CBLL struggles to generate sufficient returns from assets.

ROA > 10%
-26.29%

Valuation Score

Moderate

CBLL shows balanced valuation metrics.

PE < 25
-14.23
PEG Ratio < 2
3.44

Growth Score

Moderate

CBLL shows steady but slowing expansion.

Revenue Growth > 5%
44.71%
EPS Growth > 10%
-2.09%

Financial Health Score

Excellent

CBLL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.13
Current Ratio > 1
12.50

Profitability Score

Weak

CBLL struggles to sustain strong margins.

ROE > 15%
-2962.72%
Net Margin ≥ 15%
-63.35%
Positive Free Cash Flow
No

Key Financial Metrics

Is CBLL Expensive or Cheap?

P/E Ratio

CBLL trades at -14.23 times earnings. This suggests potential undervaluation.

-14.23

PEG Ratio

When adjusting for growth, CBLL's PEG of 3.44 indicates potential overvaluation.

3.44

Price to Book

The market values CeriBell, Inc. at 4.55 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.55

EV/EBITDA

Enterprise value stands at -15.37 times EBITDA. This is generally considered low.

-15.37

How Well Does CBLL Make Money?

Net Profit Margin

For every $100 in sales, CeriBell, Inc. keeps $-63.35 as profit after all expenses.

-63.35%

Operating Margin

Core operations generate -68.46 in profit for every $100 in revenue, before interest and taxes.

-68.46%

ROE

Management delivers $-29.63 in profit for every $100 of shareholder equity.

-29.63%

ROA

CeriBell, Inc. generates $-26.29 in profit for every $100 in assets, demonstrating efficient asset deployment.

-26.29%

Following the Money - Real Cash Generation

Operating Cash Flow

CeriBell, Inc. generates limited operating cash flow of $-40.47M, signaling weaker underlying cash strength.

$-40.47M

Free Cash Flow

CeriBell, Inc. generates weak or negative free cash flow of $-41.56M, restricting financial flexibility.

$-41.56M

FCF Per Share

Each share generates $-1.12 in free cash annually.

$-1.12

FCF Yield

CBLL converts -5.49% of its market value into free cash.

-5.49%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-14.23

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

3.44

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.55

vs 25 benchmark

P/S Ratio

Price to sales ratio

9.09

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.13

vs 25 benchmark

Current Ratio

Current assets to current liabilities

12.50

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.30

vs 25 benchmark

ROA

Return on assets percentage

-0.26

vs 25 benchmark

ROCE

Return on capital employed

-0.31

vs 25 benchmark

How CBLL Stacks Against Its Sector Peers

MetricCBLL ValueSector AveragePerformance
P/E Ratio-14.2329.43 Better (Cheaper)
ROE-29.63%800.00% Weak
Net Margin-63.35%-20145.00% (disorted) Weak
Debt/Equity0.130.30 Strong (Low Leverage)
Current Ratio12.504.64 Strong Liquidity
ROA-26.29%-17936.00% (disorted) Weak

CBLL outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CeriBell, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

88.70%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

18.64%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

18.15%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ